Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?

OBJECTIVE: To explore the potential of CT radiomics in detecting acquired T790M mutation and predicting prognosis in patients with advanced lung adenocarcinoma with progression after first- or second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaohuang, Fang, Chao, Li, Congrui, Gong, Min, Yi, Xiaochun, Lin, Huashan, Li, Kunyan, Yu, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300753/
https://www.ncbi.nlm.nih.gov/pubmed/35875167
http://dx.doi.org/10.3389/fonc.2022.904983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300753/
https://www.ncbi.nlm.nih.gov/pubmed/35875167
http://dx.doi.org/10.3389/fonc.2022.904983

Ejemplares similares